Stocktoria
Tilray Brands, Inc. TLRY
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2018-07-19
Tilray Brands, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $821.3M | $788.9M | $627.1M | $628.4M | $513.1M |
| Gross profit | $240.6M | $223.4M | $147.0M | $116.8M | $123.2M |
| R&D expense | $284,000 | $635,000 | $682,000 | $1.5M | $830,000 |
| Operating income | -$2.3B | -$174.7M | -$1.4B | -$610.4M | -$132.2M |
| Interest expense | $41.3M | $49.3M | $46.6M | $39.7M | $30.9M |
| Income tax | -$121.0M | -$26.6M | -$7.2M | -$6.5M | -$9.0M |
| Net income | -$2.2B | -$245.0M | -$1.5B | -$476.8M | -$367.4M |
| EPS (diluted) | $-2.46 | $-0.33 | $-2.35 | $-0.99 | $-1.36 |
| Operating cash flow | -$94.6M | -$30.9M | $7.9M | -$177.3M | -$44.7M |
| Cash & equivalents | $221.7M | $228.3M | $206.6M | $415.9M | $488.5M |
| Inventory | $270.9M | $252.1M | $200.6M | $245.5M | $256.4M |
| Total assets | $2.1B | $4.2B | $4.3B | $5.4B | $6.0B |
| Total liabilities | $584.8M | $778.5M | $977.3M | $1.0B | $1.6B |
| Shareholders' equity | $1.5B | $3.4B | $3.3B | $4.4B | $4.5B |
Source: SEC EDGAR filings · CIK 0001731348 · as of 2025-05-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.